Andrew Guggenhime, President and CFO at Vaxcyte, sold PCVX on Jun 18, 2026

Data as of Oct 16

▼ SELL$530K10,000 shares at $53.00Andrew Guggenhime President and CFOPCVX Vaxcyte, Inc.

Watch PCVX

Traded: Jun 18, 2026
Disclosed: Jun 18, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

PCVXSimilar stocks (XLV — its sector index fund), rebased to PCVX's price on the disclosure day

PCVX since disclosure

+23.7%

after the sale

Similar stocks (XLV) since disclosure

+18.3%

XLV — its sector index fund

Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on PCVX →